STAT Plus: Pfizer says efficacy of its Duchenne gene therapy outweighs side effects
RUBY WALLAU FOR STAT
The company said steps being taken to monitor patients, as well as higher doses of steroids given to patients, appear to be working.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario